journal article·2022-08Open access

Rapid Profiling of Tumor‐Immune Interaction Using Acoustically Assembled Patient‐Derived Cell Clusters

Zheng Ao, Zhuhao Wu, Hongwei Cai, Liya Hu, Xiang Li, Connor Kaurich, Jackson Chang, Mingxia Gu, Liang Cheng, Xin Lu, Feng Guo

Advanced Science· Volume 9· Issue 22

Abstract

Abstract Tumor microenvironment crosstalk, in particular interactions between cancer cells, T cells, and myeloid‐derived suppressor cells (MDSCs), mediates tumor initiation, progression, and response to treatment. However, current patient‐derived models such as tumor organoids and 2D cultures lack some essential niche cell types (e.g., MDSCs) and fail to model complex tumor‐immune interactions. Here, the authors present the novel acoustically assembled patient‐derived cell clusters (APCCs) that can preserve original tumor/immune cell compositions, model their interactions in 3D microenvironments, and test the treatment responses of primary tumors in a rapid, scalable, and user‐friendly manner. By incorporating a large array of 3D acoustic trappings within the extracellular matrix, hundreds of APCCs can be assembled within a petri dish within 2 min. Moreover, the APCCs can preserve sensitive and short‐lived (≈1 to 2‐day lifespan in vivo) tumor‐induced MDSCs and model their dynamic suppression of T cell tumor toxicity for up to 24 h. Finally, using the APCCs, the authors succesully model the combinational therapeutic effect of a multi‐kinase inhibitor targeting MDSCs (cabozantinib) and an anti‐PD‐1 immune checkpoint inhibitor (pembrolizumab). The novel APCCs may hold promising potential in predicting treatment response for personalized cancer adjuvant therapy as well as screening novel cancer immunotherapy and combinational therapy.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Immune cells in cancer · Cancer Cells and Metastasis · Nanoplatforms for cancer theranostics

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Intelligent Systems Engineering Indiana University Bloomington IN 47405 USA

Division of Pulmonary Biology Center for Stem Cell and Organoid Medicine (CuSTOM) Cincinnati Children's Hospital Medical Center Cincinnati OH 45229 USA

University of Cincinnati School of Medicine Cincinnati OH 45229 USA

Department of Pathology and Laboratory Medicine Indiana University School of Medicine Indianapolis IN 46202 USA

Melvin and Bren Simon Cancer Center Indiana University School of Medicine Indianapolis IN 46202 USA

Department of Biological Sciences University of Notre Dame Notre Dame IN 46556 USA

References (50)

Show source-provided references
1. 10.1016/j.cell.2011.02.01310.1016/j.cell.2011.02.013 ↗
2. 10.1038/s41571-020-0363-510.1038/s41571-020-0363-5 ↗
3. 10.1038/s41392-020-00280-x10.1038/s41392-020-00280-x ↗
4. 10.1038/nrc.2017.11710.1038/nrc.2017.117 ↗
5. 10.21037/atm-20-111410.21037/atm-20-1114 ↗
6. 10.1155/2012/76282510.1155/2012/762825 ↗
7. 10.3390/cells904101110.3390/cells9041011 ↗
8. 10.1038/cddis.2015.16210.1038/cddis.2015.162 ↗
9. 10.3389/fcell.2020.0001710.3389/fcell.2020.00017 ↗
10. 10.1172/JCI8000610.1172/JCI80006 ↗
11. 10.1016/j.immuni.2014.06.01010.1016/j.immuni.2014.06.010 ↗
12. 10.1111/j.1600-065X.2008.00608.x10.1111/j.1600-065X.2008.00608.x ↗
13. 10.4049/jimmunol.080274010.4049/jimmunol.0802740 ↗
14. 10.1158/1078-0432.CCR-07-018210.1158/1078-0432.CCR-07-0182 ↗
15. 10.3389/fimmu.2018.0131010.3389/fimmu.2018.01310 ↗
16. 10.1111/imcb.1205410.1111/imcb.12054 ↗
17. 10.1007/s00262-013-1508-510.1007/s00262-013-1508-5 ↗
18. 10.1038/nature2167610.1038/nature21676 ↗
19. 10.1158/1078-0432.CCR-05-088310.1158/1078-0432.CCR-05-0883 ↗
20. 10.1158/0008-5472.CAN-09-369010.1158/0008-5472.CAN-09-3690 ↗
21. 10.1182/blood-2007-07-09922610.1182/blood-2007-07-099226 ↗
22. 10.3389/fimmu.2019.0307010.3389/fimmu.2019.03070 ↗
23. 10.1007/s00262-019-02302-210.1007/s00262-019-02302-2 ↗
24. 10.3389/fonc.2020.0010910.3389/fonc.2020.00109 ↗
25. 10.1158/2159-8290.CD-17-083310.1158/2159-8290.CD-17-0833 ↗
26. 10.1016/j.cell.2018.11.02110.1016/j.cell.2018.11.021 ↗
27. 10.1016/j.cell.2018.07.00910.1016/j.cell.2018.07.009 ↗
28. 10.1016/j.it.2020.06.01010.1016/j.it.2020.06.010 ↗
29. 10.1038/nri250610.1038/nri2506 ↗
30. 10.1158/2159-8290.CD-15-022410.1158/2159-8290.CD-15-0224 ↗
31. 10.1038/s41590-020-0666-910.1038/s41590-020-0666-9 ↗
32. 10.1158/1535-7163.MCT-18-139910.1158/1535-7163.MCT-18-1399 ↗
33. 10.1200/jco.2014.32.15_suppl.450110.1200/jco.2014.32.15_suppl.4501 ↗
34. 10.1056/NEJMoa210639110.1056/NEJMoa2106391 ↗
35. 10.3390/cancers1301005610.3390/cancers13010056 ↗
36. 10.1016/j.molmed.2008.06.00110.1016/j.molmed.2008.06.001 ↗
37. 10.3389/fimmu.2020.0168010.3389/fimmu.2020.01680 ↗
38. 10.1016/j.tips.2018.10.00810.1016/j.tips.2018.10.008 ↗
39. 10.1038/s41577-019-0191-y10.1038/s41577-019-0191-y ↗
40. 10.1038/ni.342310.1038/ni.3423 ↗
41. 10.1016/j.semcancer.2012.01.01110.1016/j.semcancer.2012.01.011 ↗
42. 10.1016/j.canlet.2020.03.01310.1016/j.canlet.2020.03.013 ↗
43. 10.1186/s12943-020-01260-z10.1186/s12943-020-01260-z ↗
44. 10.3389/fcimb.2016.0003710.3389/fcimb.2016.00037 ↗
45. 10.3389/fimmu.2017.0189510.3389/fimmu.2017.01895 ↗
46. 10.3389/fimmu.2018.0284910.3389/fimmu.2018.02849 ↗
47. 10.1056/NEJMoa202698210.1056/NEJMoa2026982 ↗
48. 10.1158/2159-8290.CD-16-077810.1158/2159-8290.CD-16-0778 ↗
49. 10.3389/fphar.2021.71130710.3389/fphar.2021.711307 ↗
50. 10.3389/fimmu.2018.0195210.3389/fimmu.2018.01952 ↗